Clinical Trials
19 trialsNCT04997902 2026-06-05
Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Kura Oncology, Inc.
Phase 1/2 Completed
NCT06749301 2026-06-05
ADC/SCC oss
Regina Elena Cancer Institute
Completed
NCT04733495 2026-06-04
Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT05984680 2026-06-03
COPD Care Pathway Among Patients With Cancer
Wake Forest University Health Sciences
Completed
NCT07623005 2026-06-03
PMRT-ThyCa
University of Faisalabad
Phase NA Completed
NCT03258554 2026-06-02
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT04881045 2026-06-02
Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.
Pfizer
Phase 1 Completed
NCT03691714 2026-06-01
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
University of Cincinnati
Phase 2 Completed
NCT03289962 2026-05-29
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Genentech, Inc.
Phase 1 Completed
NCT05294900 2026-05-26
NEOS
Yonsei University
Phase 2 Completed
NCT02254278 2026-05-22
Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer
NRG Oncology
Phase 2 Completed
NCT02308072 2026-05-22
ORCA-2
University College, London
Phase 1 Completed
NCT03336606 2026-05-22
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
Providence Health & Services
Phase 1 Completed
NCT03789097 2026-05-22
Vaccination With Flt3L, Radiation, and Poly-ICLC
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
NCT03494322 2026-05-20
EACH
University College, London
Phase 2 Completed
NCT06054178 2026-05-20
Identification of Nerves Using Fluorescein Sodium
Stanford University
Phase 2 Completed
NCT05218824 2026-05-19
CHIRP
University of Sydney
Completed
NCT07597525 2026-05-19
Propolis for Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer
Ankara Oncology Research and Training Hospital
Phase NA Completed
NCT03650764 2026-05-15
Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine
Phase 1/2 Completed